Abstract

) The Vermont Cancer Center's Protocol Review and Monitoring System (PRMS) provides a centralized system for review and monitoring of clinical trials as required by NCI. The Protocol Review Committee (PRC), where direct protocol review is conducted, was established in April of 1993 in response to NCI's policy statement dated December 7, 1992. Oversight is also provided by the Cancer Center's Clinical Research Oversight Committee (CROC) that was established in 1998. There is a system for identification of appropriate membership, a process and criteria for the review and monitoring operations, a system of prioritization of protocols, and a well-developed working and organizational relationship with the IRB. At the last review of our Cancer Center Support Grant in December 1996, the Protocol Review and Monitoring System received conditional approval and was recommended for early peer re-evaluation. That evaluation occurred in March 1999 and our Protocol Review and Monitoring System was """"""""Approved"""""""" at that time.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022435-19
Application #
6563760
Study Section
Project Start
2001-12-01
Project End
2002-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
19
Fiscal Year
2002
Total Cost
$78,870
Indirect Cost

  Institution

Name
University of Vermont & St Agric College
Department
Type
DUNS #
066811191
City
Burlington
State
VT
Country
United States
Zip Code
05405

  Publications

Kelemen, Linda E; Abbott, Sarah; Qin, Bo et al. (2017) Cigarette smoking and the association with serous ovarian cancer in African American women: African American Cancer Epidemiology Study (AACES). Cancer Causes Control 28:699-708
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2015) Acetate supplementation as a means of inducing glioblastoma stem-like cell growth arrest. J Cell Physiol 230:1929-43
Tsen, Andrew R; Long, Patrick M; Driscoll, Heather E et al. (2014) Triacetin-based acetate supplementation as a chemotherapeutic adjuvant therapy in glioma. Int J Cancer 134:1300-10
Wagner, Darcy E; Bonenfant, Nicholas R; Parsons, Charles S et al. (2014) Comparative decellularization and recellularization of normal versus emphysematous human lungs. Biomaterials 35:3281-97
Long, Patrick M; Tighe, Scott W; Driscoll, Heather E et al. (2013) Acetate supplementation induces growth arrest of NG2/PDGFR?-positive oligodendroglioma-derived tumor-initiating cells. PLoS One 8:e80714
Sokocevic, Dino; Bonenfant, Nicholas R; Wagner, Darcy E et al. (2013) The effect of age and emphysematous and fibrotic injury on the re-cellularization of de-cellularized lungs. Biomaterials 34:3256-69
Long, Patrick M; Moffett, John R; Namboodiri, Aryan M A et al. (2013) N-acetylaspartate (NAA) and N-acetylaspartylglutamate (NAAG) promote growth and inhibit differentiation of glioma stem-like cells. J Biol Chem 288:26188-200
Bonenfant, Nicholas R; Sokocevic, Dino; Wagner, Darcy E et al. (2013) The effects of storage and sterilization on de-cellularized and re-cellularized whole lung. Biomaterials 34:3231-45
Murray, Janet M; Messier, Terri; Rivers, Jami et al. (2012) VDJ recombinase-mediated TCR ? locus gene usage and coding joint processing in peripheral T cells during perinatal and pediatric development. J Immunol 189:2356-64
Wallis, John M; Borg, Zachary D; Daly, Amanda B et al. (2012) Comparative assessment of detergent-based protocols for mouse lung de-cellularization and re-cellularization. Tissue Eng Part C Methods 18:420-32

Showing the most recent 10 out of 219 publications